Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Flagship Ventures Doubles Down On Microbiome

Executive Summary

Two of the VC's biotechs merged to create an immuno-microbiome company, while Seres is working with Emulate on better tech for microbiome research. UK specialty pharma Martindale acquired small hospital products-focused UK firm Viridian, and Bayer and X-Chem expanded their drug discovery alliance.

Advertisement

Related Content

Deal Watch: Success Nets CytomX Another $200m From BMS, Up To $3.6bn For Milestones
Tech Transfer Roundup: Voyager Brings Home Pair Of CNS Collaborations
Lilly Teams Up With Boehringer Ingelheim To Boost Abemaciclib
Servier Expands Its Immuno-Oncology Presence With Sorrento PD-1 Deal
Nichi-Iko Buys Sagent To Strengthen US Biosimilars Presence
Celyad Signs Deal With Japan's Ono For CAR-T-Like Program
Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?
Flagship Ventures Dives Into Microbiome, Launches Seres Health

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC096886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel